Stay updated with breaking news from Acarix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release (MAR)Malmö, Sweden, October 27, 2021 Acarix granted US CPT reimbursement code for CADScor System The editorial panel of the American Medical Association (AMA) today approved the Category
Press releaseMalmö, Sweden, August 27, 2021 Initial Dan-NICAD II results presented today at ESC Study confirms excellent rule-out capacity of CADScor, almost 50% of intermediate
Press release Malmö, August 19, 2021 Acarix AB (publ) publishes Interim Report, January - June 2021 Continued positive trend with focus on US expansion The second quarter continued
Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the " Company"), are hereby convened to the annual general meeting to be held on Tuesday 11 May 2021. Information with respect to the coronavirus The Company is mindful of the health and well-being of its shareholders and employees. It's important for the Company to take a social responsibility and contribute to reduce the risk of transmission of the coronavirus (Covid-19). Due to the extraordinary situation the annual general meeting will be carried out through advance voting (postal voting) p...
Acarix AB: A strong ending of an eventful year A strong ending of an eventful year The fourth quarter contributed strongly to our overall performance in 2020, with the market approval for CADScor from the US Food and Drug Administration (FDA) as the outstanding achievement. Extract from CEO Per Persson's message to the End Year Report. Fourth quarter 2020 compared with same period 2019 During the fourth quarter, 22 CADScorSystem (10, of which 4 to clinical trials) and 1,420 (1,500, of which 840 to clinical trials) disposable patches were sold to end-users and distributors. Revenue amounted to...